Louis J. Vollmer Named Iroko’s CEO
Executive Summary
Iroko Pharmaceuticals LLC. has appointed Louis J. Vollmer president and CEO. Vollmer has been president of Iroko since March 2015 and continues as a member of the company’s board of directors. He succeeds as CEO Osagie Imasogie, Iroko’s founder, who will continue as the company’s chair. Vollmer started his career at DuPont Merck where he ultimately served as vice president of sales and marketing for DuPont Multi Source Products.
You may also be interested in...
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Three New CMOs And CFOs Among This Week's Changes
Recent moves in the industry include C-suite shuffles at PureTech Health and Traws Pharma, plus Xencor gets a new chief financial officer.